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Introduction: Castleman’s disease, also known as angiofollicular lymph node hyperplasia, is a rare disease with two
known expansion types, unicentric and multicentric, which play a major role in determining therapy. We focus here
on the unicentric type, which can be treated and cured by surgery. To date, approximately 1000 cases of
Castleman’s disease have been reported in the literature.
Case presentation: A 50-year-old Caucasian woman presented to our Department of Hematology and Internal
Oncology with increasing fatigue as her sole symptom. Diagnostic investigations including laboratory studies,
ultrasound, computed tomography and magnetic resonance imaging were performed. These revealed an
interaortocaval, retroperitoneal tumor mass in her upper abdomen as the only manifestation of the disease. No
enlarged lymph nodes were detected. We conducted a laparotomy with radical extirpation of the tumor mass
(10×9×5.7cm). Complete tumor resection with clear margins was achieved. A pathological analysis of the resected
sample showed atypical lymphoid tissue of small to medium cells with some clearly visible nucleoli, enlarged
sinusoidal vessels, pleomorphic calcifications and focally preserved germinal-center-like structures. Histological and
immunohistochemical analysis confirmed the diagnosis of Castleman’s disease: staining for CD3, CD5, CD10, CD20,
CD23, CD79 and Ki-67 was strongly positive in the germinal-center-like structures. Histological findings clearly
showed the disease to be the hyaline vascular subtype. Staining for cyclin D1 and CD30 was negative. Expression of
CD15 was positive in the enlarged sinusoidal vessels. A supplementary clonality analysis was without pathological
findings. Tests for human immunodeficiency virus and human herpes virus 8 were negative and results from a bone
marrow biopsy were normal. Our patient recovered well from surgery and was discharged from our hospital.
To date, no recurrence of the disease has been detected.
Conclusion: Castleman’s disease is a rare disorder that remains a diagnostic challenge. Radical surgical resection is
considered to be the gold standard for treating the unicentric variant of this disease.
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Castleman’s disease, also known as angiofollicular lymph
node hyperplasia, is a rare disorder first described by
Benjamin Castleman in the mid-1950s. There are two
known expansion types of this disease, unicentric and
multicentric, which play a major role in determining
therapy. We focus here on the unicentric type, which
can be treated and cured by surgery. Because of the rar-
ity of this disease, epidemiological data like prevalence* Correspondence: Ilhan.Demirci@Krankenhaus-Dueren.de
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article, unless otherwise stated.or incidence are not available. The average age of pa-
tients with unicentric Castleman’s disease is around 30
to 40 years old. Patients with the multicentric form are
usually around 50 to 60 years old. No dispositional age,
race or sex seems to exist but the disease is widely asso-
ciated with human herpes virus 8 (HHV-8) and human
immunodeficiency virus (HIV) infection [1-4]. To date,
approximately 1000 cases of Castleman’s disease have
been reported in the literature [5].
Case presentation
In October 2011, a 50-year-old Caucasian woman pre-
sented to our Department of Hematology and Internaled Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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Diagnostic investigations including laboratory studies,
ultrasound, computed tomography (CT) and magnetic
resonance imaging (MRI) were performed. These re-
vealed an interaortocaval, retroperitoneal tumor mass in
her upper abdomen as the only manifestation of the dis-
ease (Figure 1). No enlarged lymph nodes were detected.
We conducted a laparotomy with radical extirpation of a
tumor mass of approximately 10×9×5.7cm and unknown
dignity (Figure 2). Complete tumor resection with clear
margins was achieved.
A pathological analysis showed atypical lymphoid tissue
of small to medium cells with some clearly visible nucleoli,
enlarged sinusoidal vessels, pleomorphic calcifications and
focally preserved germinal-center-like structures. Histo-
logical and immunohistochemical analysis confirmed the
diagnosis of Castleman’s disease (see Figure 2): staining
for CD3, CD5, CD10, CD20, CD23, CD79 and Ki-67 was
strongly positive in the germinal-center-like structures.
Histological findings clearly showed the disease to be theFigure 1 Pre-operative ultrasound, computed tomography and magn
mass of approximately 6.3×4.7×6.8cm (measured on computed tomohyaline vascular subtype. Staining for cyclin D1 and CD
30 was negative. Expression of CD15 was positive in the
above-mentioned enlarged sinusoidal vessels. A supple-
mentary clonality analysis was without pathological find-
ings. Tests for HIV and HHV-8 were negative and results
of a bone marrow biopsy were normal. Our patient recov-
ered well from the surgery and was discharged from our
hospital in early November. Follow-up care was carried
out by our Department of Hematology and Internal On-
cology. At the time of writing, no recurrence of the dis-
ease had been detected.
Discussion
The histological subtypes of Castleman’s disease are as
follows: hyaline vascular variant (unicentric in 72% of all
cases); plasma cell variant (unicentric in 18% and multi-
centric in 10% of all cases); mixed variant, and a plasma-
blastic variant of multicentric Castleman’s disease
[3,4,6-10]. The disease may occur anywhere in the
lymphatic system but is found in the thorax in 60% toetic resonance imaging scans showing an interaortocaval tumor
graphy scan).
Figure 2 Intra-operative pictures of the tumor in situ and after resection. Hematoxylin and eosin staining and exemplary immunohistochemical
staining for CD20 and for CD3. (A, C) Intraoperative pictures of the tumor in situ. (B) Resected tumor mass. (D) Hematoxylin and eosin staining
showing hyaline vascular subtype. (E) Immunohistochemical staining for CD20. (F) Immunohistochemical staining for CD3.
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localization for the unicentric type; a retroperitoneal
multicentric type is among the rarest. Only 10% to 17% of
cases involve the abdomen, of which the majority of cases
are retroperitoneal [3,11-14] (Table 1). The plasmablastic
variant of the disease is commonly associated with HHV-8
and tends to have a poor prognosis. It occurs more fre-
quently in patients who are HIV positive, although there
seems to be no correlation with CD4 count [15]. The mul-
ticentric and, especially, HHV-8-positive types are risk
factors for the development of Hodgkin lymphoma, non-
Hodgkin lymphoma and Kaposi sarcoma. Non-Hodgkin
lymphomas are mainly characterized as B-cell lymphoma
subtypes (71%). Less frequently associated non-Hodgkin
lymphomas are plasmocytoma and T-cell lymphoma
[5,16,17]. In a 2009 study, Fazakas et al. supposed a
possible etiological relationship between a coexistentTable 1 Overview of the histological variants and sex and age
disease in the literature
Histological variants Distributio
HV PC Mixed NK M F
148 9 5 37 69 79
74.37% 4.52% 2.51% 18.59% 34.67% 39.7
In total: 199 cases M:F ratio: 1:1.14
F, female; HV, hyaline vascular; M, male; NK, not known; PC, plasma cell.HHV-6 infection and multicentric plasmocytic Castleman’s
disease with POEMS syndrome (polyneuropathy, organo-
megaly, endocrinopathy, monoclonal gammopathy and
skin changes) [18].
The extent of clinical symptoms may vary widely. Un-
specific symptoms like asymptomatic to symptomatic
lymphadenopathy accompanied by fever, anemia, fatigue,
abdominal or thoracic pain, and weight loss can be ob-
served. Cutaneous symptoms like paraneoplastic pem-
phigus, erythema multiforme or lichen planus have been
described. POEMS syndrome is also known to be associ-
ated with the disease, commonly with HHV-8-positive
forms.
Laboratory studies with blood counts and measurement
of C-reactive protein, interleukin 6 and liver function
should be conducted. In addition, HIV and HHV-8 testing
should be performed. In this context, it is interesting todistribution of localized retroperitoneal Castleman’s
n of sex Distribution of age (in years)
NK Age M F NK
51 0 to 9 2 0 52
% 25.63% 10 to 19 9 6
20 to 29 7 21
30 to 39 16 18
40 to 49 14 13
50 to 59 7 7
60 to 69 12 3
70 to 79 1 0
Mean 38.25





CR LR PR RT CN NK UNEV COMP NK NREC REC Deceased NK
HV (n = 137) 77 4 4 1 0 51 67 2 67 37 0 3 97
PC (n = 9) 7 0 0 0 1 1 4 1 3 5 0 1 3
Mixed (n = 5) 5 0 0 0 0 0 3 0 2 3 0 0 2
NK (n = 37) 1 0 0 0 0 26 0 0 37 0 0 0 37
COMP, complicated postoperative course; CN, conservative; CR, conventional resection; HV, hyaline vascular; LR, laparoscopic resection; NK, not known; NREC, no
recurrence; PC, plasma cell; PR, partial resection; REC, recurrence; RT, radiation therapy; UNEV, uneventful postoperative course.
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degradation product levels have been described in the
literature [19]. Although pathological analysis still re-
mains the gold standard for diagnosis, MRI, contrast-
enhanced sonography, angiography and CT are valuable
diagnostic tools [20]. MRI can be helpful in identifying
the hypervascular appearance of the hyaline vascular
type [21]. As Michail et al. stated, Castleman’s disease
should be included in the differential diagnosis of any
hypervascular and heterogeneous tumor mass in the
retroperitoneum [22,23]. In this regard, one should
note a recently published case report of unicentric hya-
line vascular Castleman’s disease mimicking a para-
spinal schwannoma [24].
Kim et al. described two distinctive types of radiological
manifestation in abdominal Castleman’s disease: a local-
ized type with single or multiple discrete masses, and a
disseminated type with non-specific organomegaly and
lymphadenopathy [25]. Differences in enhancement be-
tween the plasma cell and hyaline vascular variants on CT
scans have been described previously. The hyaline vascular
variant is known for its high enhancement on CT imaging,
whereas the plasma cell variant shows only low enhance-
ment. However, Lu and Wu pointed out that the degree of
enhancement cannot be used as a reliable and specific
diagnostic criterion to distinguish between the above-
mentioned types [13]. In a recently published study, ‘rim-
like’ enhancement, a predominantly left-sided location in
the retroperitoneum, and the presence of peritoneal thick-
ening were described as relatively characteristic CT find-
ings of the disease. Furthermore, non-specific features like
necrosis, fibrosis and calcifications can be observed [14].
A fluorine-18-fluorodeoxyglucose positron emission tom-
ography scan can be helpful in staging of the disease, but
its role is still controversial.
Castleman’s disease remains difficult to diagnose pre-
operatively because the disease may resemble other ma-
lignant tumors. Therefore, exclusion of other diseases
with lymphadenopathy, for example lupus erythema-
todes, thymoma, sarcoma, rheumatoid arthritis, HIV in-
fection and lymphoma, is important for differentialdiagnosis [3]. According to Deschênes et al., fine-needle
aspiration can be useful in diagnosing Castleman’s dis-
ease [26]. The unicentric type - if resected completely -
is not associated with increased mortality and is known
to have an excellent prognosis (Table 2). Therefore, rad-
ical surgical resection is considered to be the gold stand-
ard therapy in these cases. According to a recently
published study, there are no differences in the surgical
outcomes of deep and superficial Castleman’s disease as
long as the resection is complete [27]. The prognosis
and outcome of the multicentric type depend on many
factors, like progression rate, infections and comorbidi-
ties, and tend to be poorer [2,4,6]. There are no clear
data about how long follow-up care should be con-
ducted. Patients treated with radiotherapy should be
closely monitored with CT scans every six months. Pa-
tients with unicentric disease should receive radiological
follow-up every six to 12 months, although a generally
accepted regimen is not established [2,4]. Appropriate
follow-up care should consider type, progression rate,
clinical course and curability of the disease, and should
always therefore be planned on a case-by-case basis.Conclusion
Castleman’s disease is a rare disorder that remains a
diagnostic challenge. Radical surgical resection is consid-
ered to be the gold standard for treating the unicentric
variant. This type is not associated with increased mor-
tality as long as resection is radical and complete.Consent
Written informed consent was obtained from the patient
for publication of this case report and any accompanying
images. A copy of the written consent is available for re-
view by the Editor-in-Chief of this journal.
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